Browse by Person (creator, editor, contributor, etc.)

Group by: Item Type | Date | No Grouping

Jump to: Article | Book section | Conference or workshop item | Book

Number of items: 18.

Article

Adamou, M. and Puchalska, S. and Plummer, W. and Hale, A.S. (2007) Valproate in the treatment of PTSD: systematic review and meta analysis. Current Medical Research and Opinion, 23 (6). pp. 1285-1291. ISSN 0300-7995. The full text of this publication is not available from this repository.

Willner, P. and Hale, A.S. and Argyropoulos, S. (2005) Dopaminergic mechanism of antidepressant action in depressed patients. Journal of Affective Disorders, 86 (1). pp. 37-45. ISSN 0165-0327. The full text of this publication is not available from this repository.

Adamou, M. and Hale, A.S. (2004) Extrapyramidal syndrome and long-acting injectable risperidone. Am J Psychiatry, 161 (4). pp. 756-757. ISSN 0002-953X. The full text of this publication is not available from this repository.

Adamou, M. and Hale, A.S. (2003) Erotomania induced by venlafaxine: a case study. ACTA PSYCHIATRICA SCANDINAVICA, 107 (4). pp. 314-317. ISSN 0001-690X. The full text of this publication is not available from this repository.

Nicholls, C.J. and Hale, A.S. and Freemantle, N. (2003) Cost-effectiveness of amisulpride compared with risperidone in patients with schizophrenia. Journal of Drug Assessment, 6 . pp. 79-90. ISSN 1369-9474. The full text of this publication is not available from this repository.

Adamou, M. and Hale, A.S. (2003) PTSD and the law of psychiatric injury in England and Wales: finally coming closer? JOURNAL- AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 31 (3). pp. 327-332. ISSN 1093-6793. The full text of this publication is not available from this repository.

Hale, A.S. (2003) The challenge of preventing relapse and recurrence. Int Clin Psychopharmacology, 18 (Supplement 1). pp. 11-18. ISSN 0268-1315. The full text of this publication is not available from this repository.

Lo, H. and Hale, A.S. and D'Haenen, H. (2002) Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. International Clinical Psychopharmacology, 17 (5). pp. 239-247. ISSN 0268-1315 . The full text of this publication is not available from this repository.

Malhi, G.S. and Hale, A.S. (2000) Comorbidity. International Journal of Psychiatry in Clinical Practice, 4 (2). p. 163. ISSN 1365-1501. The full text of this publication is not available from this repository.

Hale, A.S. and Azorin, J.M and Kasper, S. and Maier, W. and Syvalahti, E. and Van der Burght, M. and Sloth-Nielsen, M. and Wehnert, A. (2000) Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial. International Journal of Psychiatry in Clinical Practice, 4 (1). pp. 55-62. ISSN 1365-1501. The full text of this publication is not available from this repository.

Hale, A.S. and Azorin, J.M and Kasper, S. and Maier, W. and Syvalahti, E. and Van der Burght, M. and Sloth-Nielsen, M. and Wehnert, A. (2000) Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial. International Journal of Psychiatry in Clinical Practice, 4 (1). pp. 47-54. ISSN 1365-1501. The full text of this publication is not available from this repository.

Hale, A.S. (2000) Newer antipsychotics: effect in long-term studies and effectiveness in clinical practice. Nordic Journal of Psychiatry, 54 . p. 22. ISSN 0803-9488. The full text of this publication is not available from this repository.

Kasper, S. and Hale, A.S. and Azorin, J.M. and Moller, H.J. (1999) Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 249 . pp. 2-14. ISSN 0940-1334. The full text of this publication is not available from this repository.

Hale, A.S. (1997) "Curiouser and curiouser". Commentary on Antelman et al, 'Time-dependent sensitization (TDS), possible implications for clinical psychopharmacology'. Behavioural Pharmacology, 8 (6-7). pp. 517-520. ISSN 0955-8810. The full text of this publication is not available from this repository.

Book section

Hale, A.S. (2005) The treatment of depression. In: Griel, E.J.L. and Faravelli, C. and Nutt, D.J. and Zohar, J., eds. Mood Disorders: Clinical Management and Research Issues. John Wiley & Sons, pp. 293-350. ISBN 9780470094266. The full text of this publication is not available from this repository.

Conference or workshop item

Hale, A.S. (1998) A review of the safety and tolerability of sertindole. In: Symposium on New Treatment Strategies and Novel Antipsychotics - a New Window of Opportunities, Oct 03-04, Rome, Italy. The full text of this publication is not available from this repository.

Hale, A.S. 'Remission: the expectations of both doctors and patients'. In: 21st Congress of the European-College-of-Neuropsychopharmacology, Barcelona, Spain. The full text of this publication is not available from this repository.

Book

Hale, A.S. and Boyer, P. (2003) Challenges in Drug Treatment of Depression. Lipcott Williams & Wilkins The full text of this publication is not available from this repository.

This list was generated on Sat May 18 17:27:50 2013 BST.